SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-029829
Filing Date
2020-05-15
Accepted
2020-05-15 17:46:35
Documents
1
Period of Report
2020-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4067
  Complete submission text file 0001209191-20-029829.txt   5506
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Issuer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 39 BLISS AVENUE TENAFLY NJ 07670
Business Address
Dhingra Kapil (Reporting) CIK: 0001456849 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36070 | Film No.: 20887117